Owlstone Medical partners with Shanghai Renji Hospital

Owlstone Medical, a diagnostics company developing a breathalyzer for applications in early disease detection and precis...

February 25, 2019 | Monday | News
Sosei Heptares initiates new clinical development programme

Sosei Group Corporation, has announced that the first healthy subject has been dosed with a novel small molecule HTL0030...

February 22, 2019 | Friday | News
Mallinckrodt presents analysis results for Therakos against aGvHD

Mallinckrodt plc, a leading global specialty pharmaceutical company has announced interim analysis results of its compan...

February 21, 2019 | Thursday | News
Saniona announces succesful completion of preclinical development of SAN711

Saniona, a biotech company focused on CNS and eating disorders has announced the successful completion of preclinical de...

February 19, 2019 | Tuesday | News
Navitas Life Sciences acquires DataCeutics in a $45 MM deal

Navitas Life Sciences, a TAKE Solutions Enterprise has announced that it will be acquiring Life Sciences services player...

February 14, 2019 | Thursday | News
Boehringer Ingelheim, IBM to integrate blockchain tech in clinical trials

Boehringer Ingelheim (Canada) Ltd. and IBM Canada have announced at the Healthcare Information and Management Systems So...

February 14, 2019 | Thursday | News
Pfizer, Astellas announce results from Ph 3 ARCHES trial in men with mHSPC

Pfizer Inc. and Astellas Pharma Inc. have announced the results from the Phase 3 ARCHES trial in men with metastatic hor...

February 12, 2019 | Tuesday | News
“An efficient approach to clinical trial design will have the greatest impact”

The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies definin...

February 6, 2019 | Wednesday | Opinion
TLC appoints George Spencer-Green as CMO

Taiwan Liposome Company, a clinical-stage specialty pharmaceutical company dedicated to the development and commercializ...

February 5, 2019 | Tuesday | News
Eisai, Purdue Pharma announce significant data of ph 3 clinical study

Eisai Co., Ltd. and Purdue Pharma L.P. announced a six-month results from SUNRISE 2, a long-term Phase 3 clinical study ...

February 4, 2019 | Monday | News
Spero Therapeutics announces initiation of SPR720 Ph 1 Clinical Trial

Spero Therapeutics,  a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...

January 31, 2019 | Thursday | News
Ionis, Roche initiates pivotal study of RG6042 for Huntington's disease

Ionis Pharma, Inc. the leader in antisense therapeutics, has announced that its partner Roche has enrolled the firs...

January 30, 2019 | Wednesday | News
NIAID-sponsored trial of Ebola vaccines begins at Cincinnati Children's Hospital

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at...

January 29, 2019 | Tuesday | News
Dicerna announces start of Ph1 clinical trial of DCR-HBVS

Dicerna Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, today announced the dosing of the ...

January 29, 2019 | Tuesday | News
OliX announces clinical candidate for Geographic Atrophy treatment

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced the nomination of OLX10020 as a clin...

January 29, 2019 | Tuesday | News
Translate Bio announces FDA clinical hold on IND

Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transfor...

January 23, 2019 | Wednesday | News
Gamida Cell collaborates with Be The Match BioTherapies

Clinical stage Biopharmaceutical Company, Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National M...

January 23, 2019 | Wednesday | News
Redx to resume RXC004 clinical trial programme

UK based Biotechnology Company, Redx has announced that the UK’s Medicines and Healthcare products Regulatory Agen...

January 22, 2019 | Tuesday | News